Shares of Bristol Myers Squibb Co. BMY slipped 1.55% to $46.88 Thursday, on what proved to be an all-around positive trading ...

Chinese Vice Premier He Lipeng began talks with U.S. Treasury Secretary Scott Bessent early on Saturday in Geneva in a ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

Shares of Bristol Myers Squibb Co. BMY shed 1.01% to $50.06 Monday, on what proved to be an all-around grim trading session ...

(Reuters) -Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

Hawaii will receive $700 million in a landmark settlement from pharmaceutical giants Bristol Myers Squibb and Sanofi following more than a decade of litigation over the blood thinner Plavix and its ...

Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here to find out why BMY stock is a Buy.

Bristol Myers Squibb, the pharmaceutical company headquartered in New Jersey, announced plans to lay off more than 500 ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less ...

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.